Pharmafile Logo

CHCR The Centre for Health Communications Research

CHCR is a research centre offering healthcare communication consultancy, professional development and training including the first UK Postgraduate Certificate in Health Communications.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

c/o CHCR Enterprises @Bucks New University, Uxbridge Campus, 106 Oxford Road, Uxbridge, Middlesex, UB8 1NA, UK
01252 792981

 Latest Content from PMHub 

The strategic role of AI in scaling Design Systems across channels

How can pharma teams scale AI safely across channels? In this session, Ed Hart and Nicolas Barcza explore why strong Design Systems are the foundation for making AI operational, compliant...

Uniphar | Clinical merges with BMclinical to strengthen global clinical trial services

Press Releases | February 16, 2026 | Uniphar

Leading global healthcare services provider Uniphar announces a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and biotech companies worldwide.   As part of Uniphar’s global platform supporting...

What HCPs want from digital pharma in 2026: The value gap

We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

Press Releases | February 13, 2026 | Medscape Education

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Press Releases | February 12, 2026 | Medscape Education

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Cuttsy+Cuttsy becomes employee owned

Press Releases | February 9, 2026 | Cuttsy + Cuttsy

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.

New Webinar: 2026 Engagement Strategies For Modern Pharma

Press Releases | February 5, 2026 | Impetus Digital

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Why Sleep Health is the Missing Link in Women’s Wellness

Press Releases | February 5, 2026 | Medscape Education

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

MFN Pricing Is Moving Fast – Here’s What Matters

With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — and yes, it's a lot to digest. In a new...

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...